Daiwa Securities Group Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 158 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$01380.0%0.00%
Q2 2023$0
-100.0%
1380.0%0.00%
Q1 2023$11380.0%0.00%
Q4 2022$0
-100.0%
1380.0%0.00%
Q3 2022$1,0000.0%1380.0%0.00%
Q2 2022$1,0000.0%1380.0%0.00%
Q1 2022$1,0000.0%1380.0%0.00%
Q4 2021$1,0000.0%1380.0%0.00%
Q3 2021$1,0000.0%1380.0%0.00%
Q2 2021$1,0000.0%1380.0%0.00%
Q1 2021$1,000
-50.0%
1380.0%0.00%
Q4 2020$2,000
-66.7%
138
-66.9%
0.00%
Q3 2020$6,000
-14.3%
417
+17.8%
0.00%
Q2 2020$7,0000.0%3540.0%0.00%
Q1 2020$7,0000.0%3540.0%0.00%
Q4 2019$7,000
+75.0%
354
-7.6%
0.00%
Q3 2019$4,000
+100.0%
3830.0%0.00%
Q2 2019$2,0000.0%383
+46.7%
0.00%
Q1 2019$2,0000.0%2610.0%0.00%
Q4 2018$2,000
-50.0%
2610.0%0.00%
Q3 2018$4,0000.0%2610.0%0.00%
Q2 2018$4,0000.0%2610.0%0.00%
Q1 2018$4,0002610.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders